Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF in Chinese CHB Subjects Following Failure of Multiple NAs
NCT02195518Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by GSK. Started Mar 2015; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02195518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195518.